Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05816226 · ClinicalTrials.gov registry record · Phase 3
Topical Treatment for TMJ Arthralgia
A Phase 3 study of TMJ Pain, sponsored by University of the Pacific.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT05816226 is a Phase 3 study of TMJ Pain that is actively recruiting participants, run by University of the Pacific. The registered enrollment target is 90 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05816226, a Phase 3 study of TMJ Pain, is actively recruiting participants, sponsored by University of the Pacific.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to evaluate the efficacy of topical 2.5% hydrocortisone in TMJ arthralgia. The main questions it aims to answer are: * How does pain reduction compare? * How does improvement in jaw function limitation compare? * How do side effects compare? Participants will * On day 1 be examined and report their pain level and jaw function limitation * On days 1-21, apply their cream four times a day * On day 21, report their pain level, jaw function limitation, compliance with instructions, and side effects. Researchers will compare topical 2.5% hydrocortisone and topical 1% diclofenac to see if efficacy and side effects differ.
Conditions Studied
Interventions
- DRUG Hydrocortisone 2.5%
- DRUG Diclofenac 1% topical
Study Locations (1)
California
- Arthur A. Dugoni School of Dentistry, University of the Pacific - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2026-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05816226
The ClinicalTrials.gov registry entry for NCT05816226 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of the Pacific, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with TMJ Pain appearing as the primary indexed condition, and to 2 interventions - of which Hydrocortisone 2.5% is the first listed.
NCT05816226 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05816226 about?
NCT05816226 is a clinical study titled "Topical Treatment for TMJ Arthralgia". The goal of this clinical trial is to evaluate the efficacy of topical 2.5% hydrocortisone in TMJ arthralgia. The main questions it aims to answer are: * How does pain reduction compare? * How does improvement in jaw function limitation compare? * How do side effects compare? Participants will * On...
What is the current status of trial NCT05816226?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 90 participants. The study started on 2023-06-01. Estimated completion is 2026-04.
What conditions does trial NCT05816226 study?
This clinical trial studies the following conditions: TMJ Pain.
What interventions are being tested in trial NCT05816226?
The interventions under investigation include: Hydrocortisone 2.5% (DRUG), Diclofenac 1% topical (DRUG).
Who is sponsoring clinical trial NCT05816226?
This trial is sponsored by University of the Pacific, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05816226 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.